• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Silo Pharma Inc (OP: SILO )

    N/A UNCHANGED
    Last Price Updated: 3:23 PM EDT, Sep 14, 2022 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.1700
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    San Francisco Passes Resolution to Decriminalize Psilocybin Mushrooms
    Via Investor Brand Network
    This Psychedelics Company Is Undertaking A 1:50 Reverse Stock Split To Enter NASDAQ
    The psychedelics landscape changes quickly. Whether large or small, every biotech company is looking for ways to further advance their research and product & services commercialization.  
    Via Benzinga

    Performance

    More News

    Read More
    Study Finds Depression Symptoms in Partners Caring for Dementia Patients May Start Long Before Cognitive Decline
    Via Investor Brand Network
    Georgia Legislators Discuss Psychedelics for Veterans During Committee Hearing
    Via Investor Brand Network
    New Research Finds Link Between Psychedelic-Induced Mystical Experiences and EcoFriendly Behavior
    Via Investor Brand Network
    Silo Pharma Inc. (SILO): Promising Psylocibin Study Ongoing with UCSF
    Via Investor Brand Network
    Research Indicates Better Sleep Efficiency Benefits Fibromyalgia Sufferers
    Via Investor Brand Network
    Important Factors to Consider When Designing Psychedelic Clinical Trial Protocols
    Via Investor Brand Network
    Psychedelics Company Raises More than $10M in Seed Funding to Advance Ketamine Therapy
    Via Investor Brand Network
    Study Explains How Threatening Cues Are Refined into Fear Signals
    Via Investor Brand Network
    PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Fusing Traditional Therapeutics with Psychedelic Research
    Via Investor Brand Network
    Study Finds More Than 5.5 Million Adults in the US Use Hallucinogens
    Via Investor Brand Network
    California Senator Sees New Path to Get Psychedelics Decriminalization Bill Approved
    Via Investor Brand Network
    Study Finds Vitamin D May Help Alleviate Depression Symptoms
    Via Investor Brand Network
    Psychedelics Advocates Put DEA Under Pressure Over Right to Try Laws
    Via Investor Brand Network
    Second Psychedelics Initiative Fails to Qualify for Colorado Ballot
    Via Investor Brand Network
    PsychedelicNewsBreaks – Silo Pharma Inc.’s (SILO) Ketamine Study Generates ‘Extremely Promising’ Data
    Via Investor Brand Network
    Study Finds Smells Experienced in Nature Boost Mental Health
    Via Investor Brand Network
    Leading Neuroscientist Explains How Psychedelics Alters the Brain
    Via Investor Brand Network
    BioMedNewsBreaks – Silo Pharma Inc. (SILO) Reports Positive Results from Research on Novel Liposomes
    Via Investor Brand Network
    Three Clinical Trials On Psychedelic Microdosing Worth Following
    Via Investor Brand Network
    Silo Pharma Inc.’s (SILO) Ketamine Study Produces Positive Endpoint Results, Suggests Topical Formulation Reduces Neuropathic Nerve Pain
    Via Investor Brand Network
    Research Finds That Tourism, Travel May Boost Mental Health
    Via Investor Brand Network
    The DEA Rescinds Proposal to Ban Five Psychedelics
    Via Investor Brand Network
    Preclinical Ketamine Trial Shows Positive Results For Pain Conditions Like Fibromyalgia And Arthritis
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.